The 2 linked references in paper Н. Новикова А., А. Воловченко Н. (2016) “СНИЖЕНИЕ РИСКА СЕРДЕЧНО-СОСУДИСТОЙ СМЕРТНОСТИ И ИНСУЛЬТА У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ” / spz:neicon:aterotromboz:y:2016:i:2:p:81-88

  1. January CT, Wann ST, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society: Executive summary. JACC, 2014: doi:10.1016/j.jacc.2014.03.021.
  2. Graham DJ, Reichman ME, Wernecke M et al. Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated with Dabigatran or Warfarin for Non-Valvular Atrial Fibrillation. Circulation, published online October 30, 2014, doi: 10.1161/Circulation AHA.114.012061.